Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes

Fig. 5

Validation of the metabolism-based prognostic risk signature in the GSE31210 cohort. The risk score distribution of LUAD patients; Survival status and duration of patients; Heatmap of the metabolism-related genes expression; Survival curves for the low risk and high risk groups; Time-independent ROC analysis of risk scores for prediction the overall survival in the GSE31210 dataset

Back to article page